A Phase 1 Dose Escalation Study of the Oral Selective Inhibitor of Nuclear Export (SINE) Selexinor (KPT-330) in Patients with Relapsed / Refractory Acute Myeloid Leukemia (AML)
A Phase 1 Dose Escalation Study of the Oral Selective Inhibitor of Nuclear Export (SINE) Selexinor (KPT-330) in Patients with Relapsed / Refractory Acute Myeloid Leukemia (AML)